To see if blocking the crosstalk between adipose tissue and tumors with a neutralizing antibody against CCL2 can suppress cancer progression, we conducted in vivo experiments and analyzed key genes and proteins involved in their interaction. The gene discussed is CCL2; the disease is cancer.